| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.30e-16 | 46 | 22 | 8 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.52e-11 | 188 | 22 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.54e-07 | 12 | 22 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.79e-06 | 891 | 22 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | dATP binding | 1.16e-05 | 5 | 22 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.73e-05 | 6 | 22 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 2.43e-05 | 7 | 22 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 4.15e-05 | 9 | 22 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.46e-04 | 156 | 22 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | integrin binding | 9.01e-04 | 175 | 22 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparin binding | 1.18e-03 | 192 | 22 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.43e-03 | 51 | 22 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 2.17e-03 | 63 | 22 | 2 | GO:0030544 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.05e-03 | 268 | 22 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.14e-03 | 323 | 22 | 3 | GO:1901681 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 5.17e-03 | 98 | 22 | 2 | GO:0048306 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 8.40e-03 | 126 | 22 | 2 | GO:0051082 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.34e-02 | 161 | 22 | 2 | GO:0051087 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.37e-02 | 163 | 22 | 2 | GO:0031072 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.43e-02 | 1356 | 22 | 5 | GO:0060090 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 6.01e-08 | 377 | 21 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 6.12e-08 | 378 | 21 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 6.23e-08 | 379 | 21 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 9.85e-06 | 5 | 21 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | regulation of protein refolding | 1.48e-05 | 6 | 21 | 2 | GO:0061083 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 2.07e-05 | 7 | 21 | 2 | GO:1903333 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 6.10e-05 | 76 | 21 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 8.92e-05 | 14 | 21 | 2 | GO:1903332 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.36e-04 | 266 | 21 | 4 | GO:0033044 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA destabilization | 1.67e-04 | 19 | 21 | 2 | GO:0061158 | |
| GeneOntologyBiologicalProcess | protein refolding | 4.22e-04 | 30 | 21 | 2 | GO:0042026 | |
| GeneOntologyBiologicalProcess | skin development | 4.94e-04 | 373 | 21 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 5.60e-04 | 161 | 21 | 3 | GO:0071230 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 5.76e-04 | 35 | 21 | 2 | GO:0051085 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 7.37e-04 | 177 | 21 | 3 | GO:0071229 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 7.90e-04 | 41 | 21 | 2 | GO:0051084 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 8.69e-04 | 43 | 21 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 9.10e-04 | 44 | 21 | 2 | GO:0048026 | |
| GeneOntologyBiologicalProcess | COPII-coated vesicle budding | 9.52e-04 | 45 | 21 | 2 | GO:0090114 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 9.95e-04 | 46 | 21 | 2 | GO:0006458 | |
| GeneOntologyBiologicalProcess | response to amino acid | 1.08e-03 | 202 | 21 | 3 | GO:0043200 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.13e-03 | 49 | 21 | 2 | GO:0050685 | |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 1.37e-03 | 54 | 21 | 2 | GO:0006513 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 1.53e-03 | 228 | 21 | 3 | GO:0001101 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.86e-03 | 63 | 21 | 2 | GO:0033120 | |
| GeneOntologyBiologicalProcess | protein folding | 1.90e-03 | 246 | 21 | 3 | GO:0006457 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.10e-03 | 551 | 21 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 2.20e-03 | 259 | 21 | 3 | GO:1903313 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A1 COL4A4 COL5A1 COL21A1 WDR33 COL5A3 COL22A1 COL16A1 | 1.30e-16 | 88 | 22 | 9 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.59e-11 | 21 | 22 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.81e-10 | 332 | 22 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.79e-08 | 530 | 22 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.95e-07 | 656 | 22 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.00e-07 | 658 | 22 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.21e-07 | 12 | 22 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.21e-07 | 12 | 22 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type V trimer | 6.34e-06 | 4 | 22 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.58e-05 | 6 | 22 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.95e-05 | 8 | 22 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.95e-05 | 8 | 22 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.95e-05 | 8 | 22 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 1.26e-04 | 16 | 22 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | basement membrane | 2.75e-04 | 122 | 22 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.12e-03 | 1187 | 22 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.05e-03 | 64 | 22 | 2 | GO:0012507 | |
| GeneOntologyCellularComponent | vesicle coat | 2.24e-03 | 67 | 22 | 2 | GO:0030120 | |
| GeneOntologyCellularComponent | membrane coat | 5.51e-03 | 106 | 22 | 2 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 5.51e-03 | 106 | 22 | 2 | GO:0048475 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 5.92e-03 | 110 | 22 | 2 | GO:0030134 | |
| GeneOntologyCellularComponent | chromosomal region | 9.40e-03 | 421 | 22 | 3 | GO:0098687 | |
| GeneOntologyCellularComponent | kinetochore | 1.54e-02 | 181 | 22 | 2 | GO:0000776 | |
| HumanPheno | Cervical insufficiency | 6.93e-06 | 4 | 6 | 2 | HP:0030009 | |
| HumanPheno | Dilatation of the cerebral artery | 1.85e-05 | 51 | 6 | 3 | HP:0004944 | |
| HumanPheno | Molluscoid pseudotumors | 2.42e-05 | 7 | 6 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 2.42e-05 | 7 | 6 | 2 | HP:0000139 | |
| HumanPheno | Genital hernia | 3.23e-05 | 8 | 6 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 3.23e-05 | 8 | 6 | 2 | HP:0025019 | |
| HumanPheno | Pulmonary artery aneurysm | 3.23e-05 | 8 | 6 | 2 | HP:0004937 | |
| HumanPheno | Cigarette-paper scars | 5.18e-05 | 10 | 6 | 2 | HP:0001073 | |
| HumanPheno | Arterial dissection | 7.59e-05 | 12 | 6 | 2 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 7.59e-05 | 12 | 6 | 2 | HP:0004947 | |
| HumanPheno | Abnormal uterine cervix morphology | 8.97e-05 | 13 | 6 | 2 | HP:0012888 | |
| HumanPheno | Pulmonary artery dilatation | 1.05e-04 | 14 | 6 | 2 | HP:0004927 | |
| HumanPheno | Premature rupture of membranes | 1.56e-04 | 17 | 6 | 2 | HP:0001788 | |
| HumanPheno | Blue sclerae | 1.77e-04 | 108 | 6 | 3 | HP:0000592 | |
| HumanPheno | Abnormality of refraction | 2.74e-04 | 709 | 6 | 5 | HP:0000539 | |
| HumanPheno | Abnormal sclera morphology | 3.91e-04 | 141 | 6 | 3 | HP:0000591 | |
| HumanPheno | Dermal translucency | 4.01e-04 | 27 | 6 | 2 | HP:0010648 | |
| HumanPheno | Migraine | 5.07e-04 | 154 | 6 | 3 | HP:0002076 | |
| HumanPheno | Cerebellar cyst | 6.32e-04 | 166 | 6 | 3 | HP:0002350 | |
| HumanPheno | Abnormal cerebral artery morphology | 6.90e-04 | 171 | 6 | 3 | HP:0009145 | |
| HumanPheno | Bladder diverticulum | 7.16e-04 | 36 | 6 | 2 | HP:0000015 | |
| HumanPheno | Atrophic scars | 7.56e-04 | 37 | 6 | 2 | HP:0001075 | |
| HumanPheno | Fragile skin | 7.56e-04 | 37 | 6 | 2 | HP:0001030 | |
| HumanPheno | Myopia | 7.61e-04 | 447 | 6 | 4 | HP:0000545 | |
| HumanPheno | Abnormal arterial physiology | 8.15e-04 | 181 | 6 | 3 | HP:0025323 | |
| HumanPheno | Vascular dilatation | 1.35e-03 | 215 | 6 | 3 | HP:0002617 | |
| HumanPheno | Intracranial cystic lesion | 1.42e-03 | 219 | 6 | 3 | HP:0010576 | |
| HumanPheno | Central nervous system cyst | 1.48e-03 | 222 | 6 | 3 | HP:0030724 | |
| HumanPheno | Finger joint hypermobility | 1.49e-03 | 52 | 6 | 2 | HP:0006094 | |
| HumanPheno | Abnormalities of the peripheral arteries | 1.56e-03 | 226 | 6 | 3 | HP:0005114 | |
| HumanPheno | Cortical dysplasia | 1.73e-03 | 56 | 6 | 2 | HP:0002539 | |
| HumanPheno | Joint hypermobility | 1.77e-03 | 557 | 6 | 4 | HP:0001382 | |
| HumanPheno | Abnormality of hand joint mobility | 1.79e-03 | 57 | 6 | 2 | HP:0006256 | |
| HumanPheno | Ecchymosis | 1.86e-03 | 58 | 6 | 2 | HP:0031364 | |
| HumanPheno | Osteoarthritis | 2.33e-03 | 65 | 6 | 2 | HP:0002758 | |
| Domain | Collagen | COL3A1 COL4A1 COL4A4 COL5A1 COL21A1 WDR33 COL5A3 COL22A1 COL16A1 | 2.57e-16 | 85 | 22 | 9 | PF01391 |
| Domain | Collagen | COL3A1 COL4A1 COL4A4 COL5A1 COL21A1 WDR33 COL5A3 COL22A1 COL16A1 | 2.57e-16 | 85 | 22 | 9 | IPR008160 |
| Domain | TSPN | 4.62e-11 | 23 | 22 | 5 | SM00210 | |
| Domain | Laminin_G | 6.12e-09 | 58 | 22 | 5 | IPR001791 | |
| Domain | Fib_collagen_C | 2.33e-07 | 11 | 22 | 3 | IPR000885 | |
| Domain | NC1_FIB | 2.33e-07 | 11 | 22 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 2.33e-07 | 11 | 22 | 3 | PD002078 | |
| Domain | COLFI | 2.33e-07 | 11 | 22 | 3 | SM00038 | |
| Domain | COLFI | 2.33e-07 | 11 | 22 | 3 | PF01410 | |
| Domain | - | 4.28e-06 | 95 | 22 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 4.74e-06 | 219 | 22 | 5 | IPR013320 | |
| Domain | C4 | 1.98e-05 | 6 | 22 | 2 | SM00111 | |
| Domain | - | 1.98e-05 | 6 | 22 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.98e-05 | 6 | 22 | 2 | IPR001442 | |
| Domain | NC1_IV | 1.98e-05 | 6 | 22 | 2 | PS51403 | |
| Domain | C4 | 1.98e-05 | 6 | 22 | 2 | PF01413 | |
| Domain | STI1_HS-bd | 5.93e-05 | 10 | 22 | 2 | IPR006636 | |
| Domain | STI1 | 5.93e-05 | 10 | 22 | 2 | SM00727 | |
| Domain | - | 8.71e-05 | 74 | 22 | 3 | 3.40.50.410 | |
| Domain | VWF_A | 2.07e-04 | 99 | 22 | 3 | IPR002035 | |
| Domain | Laminin_G_2 | 1.01e-03 | 40 | 22 | 2 | PF02210 | |
| Domain | LamG | 1.22e-03 | 44 | 22 | 2 | SM00282 | |
| Domain | VWA | 1.96e-03 | 56 | 22 | 2 | PF00092 | |
| Domain | VWFA | 4.15e-03 | 82 | 22 | 2 | PS50234 | |
| Domain | VWA | 4.36e-03 | 84 | 22 | 2 | SM00327 | |
| Domain | TPR_1 | 4.98e-03 | 90 | 22 | 2 | PF00515 | |
| Domain | TPR_1 | 4.98e-03 | 90 | 22 | 2 | IPR001440 | |
| Domain | CTDL_fold | 6.97e-03 | 107 | 22 | 2 | IPR016187 | |
| Domain | TPR | 9.99e-03 | 129 | 22 | 2 | SM00028 | |
| Domain | TPR-contain_dom | 1.33e-02 | 150 | 22 | 2 | IPR013026 | |
| Domain | TPR | 1.60e-02 | 165 | 22 | 2 | PS50005 | |
| Domain | TPR_REGION | 1.60e-02 | 165 | 22 | 2 | PS50293 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.96e-16 | 44 | 18 | 8 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.12e-15 | 67 | 18 | 8 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.19e-14 | 41 | 18 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.34e-14 | 90 | 18 | 8 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.10e-13 | 61 | 18 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.03e-12 | 76 | 18 | 7 | MM14573 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.83e-11 | 20 | 18 | 5 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.23e-10 | 64 | 18 | 6 | M26953 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.54e-10 | 76 | 18 | 6 | MM14867 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.65e-10 | 32 | 18 | 5 | MM14924 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.04e-10 | 85 | 18 | 6 | M16441 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.04e-10 | 38 | 18 | 5 | MM14969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.39e-09 | 300 | 18 | 8 | M610 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.53e-09 | 42 | 18 | 5 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.45e-09 | 46 | 18 | 5 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.78e-09 | 50 | 18 | 5 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.11e-09 | 53 | 18 | 5 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.43e-09 | 57 | 18 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.13e-09 | 58 | 18 | 5 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.88e-09 | 59 | 18 | 5 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.05e-08 | 61 | 18 | 5 | M27103 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.24e-08 | 63 | 18 | 5 | M11187 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.45e-08 | 140 | 18 | 6 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.70e-08 | 258 | 18 | 7 | MM14572 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.82e-08 | 74 | 18 | 5 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.23e-08 | 76 | 18 | 5 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.37e-08 | 84 | 18 | 5 | M7098 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.23e-07 | 43 | 18 | 4 | M39565 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.49e-07 | 114 | 18 | 5 | MM14571 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.28e-06 | 66 | 18 | 4 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.67e-06 | 19 | 18 | 3 | MM15512 | |
| Pathway | WP_FOCAL_ADHESION | 2.90e-06 | 187 | 18 | 5 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.93e-06 | 199 | 18 | 5 | M7253 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.02e-06 | 27 | 18 | 3 | M27217 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.95e-06 | 30 | 18 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.95e-06 | 30 | 18 | 3 | MM15517 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.47e-05 | 261 | 18 | 5 | MM15676 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.81e-05 | 41 | 18 | 3 | M27778 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.74e-05 | 47 | 18 | 3 | MM14925 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.97e-05 | 302 | 18 | 5 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.29e-05 | 326 | 18 | 5 | MM15917 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.89e-05 | 10 | 18 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.89e-05 | 10 | 18 | 2 | MM1560 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.96e-05 | 67 | 18 | 3 | MM15345 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 8.41e-05 | 11 | 18 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.01e-04 | 12 | 18 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.19e-04 | 13 | 18 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.19e-04 | 13 | 18 | 2 | M12950 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.30e-04 | 79 | 18 | 3 | M27643 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.39e-04 | 14 | 18 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.39e-04 | 14 | 18 | 2 | M6487 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.39e-04 | 418 | 18 | 5 | MM15587 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.60e-04 | 15 | 18 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.60e-04 | 15 | 18 | 2 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.33e-04 | 18 | 18 | 2 | M27164 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 2.33e-04 | 18 | 18 | 2 | M39421 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.33e-04 | 18 | 18 | 2 | MM14882 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.60e-04 | 19 | 18 | 2 | M27221 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.89e-04 | 20 | 18 | 2 | M15394 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.27e-04 | 502 | 18 | 5 | MM14537 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.83e-04 | 23 | 18 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.83e-04 | 23 | 18 | 2 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.28e-04 | 532 | 18 | 5 | M27870 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 5.71e-04 | 28 | 18 | 2 | MM15957 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.11e-04 | 575 | 18 | 5 | M29853 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.56e-04 | 30 | 18 | 2 | M27216 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.28e-03 | 1432 | 18 | 7 | M509 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.35e-03 | 43 | 18 | 2 | M53 | |
| Pathway | WP_FOCAL_ADHESION | 1.93e-03 | 199 | 18 | 3 | M39402 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.84e-03 | 73 | 18 | 2 | MM14948 | |
| Pathway | PID_REG_GR_PATHWAY | 4.81e-03 | 82 | 18 | 2 | M115 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 5.05e-03 | 84 | 18 | 2 | M3228 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.02e-03 | 92 | 18 | 2 | MM14951 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.54e-03 | 96 | 18 | 2 | M39834 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.81e-03 | 98 | 18 | 2 | M27152 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 1.19e-02 | 725 | 18 | 4 | M27507 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.76e-02 | 161 | 18 | 2 | M39770 | |
| Pubmed | 1.16e-11 | 175 | 22 | 7 | 28071719 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.17e-10 | 135 | 22 | 6 | 28675934 | |
| Pubmed | 2.20e-10 | 3 | 22 | 3 | 34691289 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.93e-10 | 62 | 22 | 5 | 28344315 | |
| Pubmed | 4.62e-10 | 153 | 22 | 6 | 25037231 | ||
| Pubmed | 7.84e-10 | 167 | 22 | 6 | 22159717 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 4.39e-09 | 6 | 22 | 3 | 3571333 | |
| Pubmed | 1.84e-08 | 9 | 22 | 3 | 8900172 | ||
| Pubmed | 2.63e-08 | 10 | 22 | 3 | 2446864 | ||
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 2.71e-08 | 50 | 22 | 4 | 27716508 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.95e-08 | 154 | 22 | 5 | 16055720 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 6.26e-08 | 13 | 22 | 3 | 36335435 | |
| Pubmed | 1.22e-07 | 16 | 22 | 3 | 17881772 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.85e-07 | 1082 | 22 | 8 | 38697112 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.46e-07 | 86 | 22 | 4 | 28327460 | |
| Pubmed | 2.90e-07 | 21 | 22 | 3 | 27856617 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 14970208 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26910848 | ||
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 3.82e-07 | 2 | 22 | 2 | 35562743 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.00e-07 | 97 | 22 | 4 | 27559042 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.44e-07 | 807 | 22 | 7 | 22681889 | |
| Pubmed | Cathepsin B Regulates Collagen Expression by Fibroblasts via Prolonging TLR2/NF-κB Activation. | 1.15e-06 | 3 | 22 | 2 | 27648120 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 26406420 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 1.15e-06 | 3 | 22 | 2 | 1571108 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 6501291 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 33819468 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 15908193 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 37158802 | ||
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 1.15e-06 | 3 | 22 | 2 | 15136578 | |
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 1.15e-06 | 3 | 22 | 2 | 17453912 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7346227 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 30273997 | ||
| Pubmed | 1.75e-06 | 615 | 22 | 6 | 31048545 | ||
| Pubmed | 2.06e-06 | 146 | 22 | 4 | 27068509 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.29e-06 | 4 | 22 | 2 | 7827955 | |
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 2.29e-06 | 4 | 22 | 2 | 25073002 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12874293 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 32945508 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 3.11e-06 | 162 | 22 | 4 | 31363146 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 9409248 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 3.82e-06 | 5 | 22 | 2 | 14758483 | |
| Pubmed | 4.22e-06 | 50 | 22 | 3 | 23658023 | ||
| Pubmed | 4.35e-06 | 399 | 22 | 5 | 35987950 | ||
| Pubmed | 5.37e-06 | 186 | 22 | 4 | 20452482 | ||
| Pubmed | 5.37e-06 | 186 | 22 | 4 | 20673868 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 5.72e-06 | 6 | 22 | 2 | 10534397 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 10722718 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 5.72e-06 | 6 | 22 | 2 | 9506531 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 5.72e-06 | 6 | 22 | 2 | 23551189 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 7495302 | ||
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 5.72e-06 | 6 | 22 | 2 | 6811420 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 11732842 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 5.72e-06 | 6 | 22 | 2 | 17029294 | |
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 5.72e-06 | 6 | 22 | 2 | 19275937 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 5.72e-06 | 6 | 22 | 2 | 6389236 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 5.72e-06 | 6 | 22 | 2 | 9673377 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 2426947 | ||
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 5.72e-06 | 6 | 22 | 2 | 19893454 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 12225806 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 10416788 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 12847218 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 10639489 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 7521231 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 8.01e-06 | 7 | 22 | 2 | 8006028 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 23273220 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 8.01e-06 | 7 | 22 | 2 | 10716744 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 1724753 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.85e-06 | 462 | 22 | 5 | 31138677 | |
| Pubmed | 9.87e-06 | 217 | 22 | 4 | 30619736 | ||
| Pubmed | 1.04e-05 | 220 | 22 | 4 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.04e-05 | 220 | 22 | 4 | 35785414 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 24503541 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 10382266 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 3997552 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.07e-05 | 8 | 22 | 2 | 33875569 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.07e-05 | 8 | 22 | 2 | 9382709 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 1.07e-05 | 8 | 22 | 2 | 20059976 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 29422532 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 15872058 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 1383086 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 18816857 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.07e-05 | 8 | 22 | 2 | 11867580 | |
| Pubmed | 1.11e-05 | 484 | 22 | 5 | 31995728 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 8562707 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 9878537 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 12101409 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 10880400 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 8995276 | ||
| Pubmed | 1.48e-05 | 1371 | 22 | 7 | 36244648 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 14559231 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.71e-05 | 10 | 22 | 2 | 15345741 | |
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 9136074 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 9415455 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.77e-05 | 922 | 22 | 6 | 27609421 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.89e-05 | 1425 | 22 | 7 | 30948266 | |
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 2745554 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 2.09e-05 | 11 | 22 | 2 | 7500359 | |
| Interaction | WWP2 interactions | 1.11e-07 | 840 | 22 | 9 | int:WWP2 | |
| Interaction | C1QTNF1 interactions | 1.84e-07 | 47 | 22 | 4 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 2.18e-07 | 49 | 22 | 4 | int:LAIR2 | |
| Interaction | SAA1 interactions | 3.25e-07 | 54 | 22 | 4 | int:SAA1 | |
| Interaction | COL1A2 interactions | 1.44e-06 | 78 | 22 | 4 | int:COL1A2 | |
| Interaction | WWOX interactions | 3.10e-06 | 627 | 22 | 7 | int:WWOX | |
| Interaction | MAG interactions | 4.05e-06 | 29 | 22 | 3 | int:MAG | |
| Interaction | KLHL12 interactions | 4.56e-06 | 104 | 22 | 4 | int:KLHL12 | |
| Interaction | PDGFA interactions | 5.49e-06 | 32 | 22 | 3 | int:PDGFA | |
| Interaction | CELF1 interactions | 1.24e-05 | 288 | 22 | 5 | int:CELF1 | |
| Interaction | PLOD1 interactions | 1.33e-05 | 292 | 22 | 5 | int:PLOD1 | |
| Interaction | DCN interactions | 1.35e-05 | 43 | 22 | 3 | int:DCN | |
| Interaction | EWSR1 interactions | 3.42e-05 | 906 | 22 | 7 | int:EWSR1 | |
| Interaction | MECP2 interactions | 3.86e-05 | 1287 | 22 | 8 | int:MECP2 | |
| Interaction | AATF interactions | 4.46e-05 | 376 | 22 | 5 | int:AATF | |
| Interaction | TNIP2 interactions | 4.69e-05 | 952 | 22 | 7 | int:TNIP2 | |
| Interaction | COL5A3 interactions | 5.09e-05 | 10 | 22 | 2 | int:COL5A3 | |
| Interaction | COLGALT2 interactions | 5.17e-05 | 67 | 22 | 3 | int:COLGALT2 | |
| Interaction | MMP9 interactions | 5.17e-05 | 67 | 22 | 3 | int:MMP9 | |
| Interaction | BMI1 interactions | 5.70e-05 | 659 | 22 | 6 | int:BMI1 | |
| Interaction | AR interactions | 6.09e-05 | 992 | 22 | 7 | int:AR | |
| Interaction | COL4A2 interactions | 7.25e-05 | 75 | 22 | 3 | int:COL4A2 | |
| Interaction | ST13P5 interactions | 7.46e-05 | 12 | 22 | 2 | int:ST13P5 | |
| Interaction | EIF4G1 interactions | 8.71e-05 | 433 | 22 | 5 | int:EIF4G1 | |
| Interaction | CEBPB interactions | 8.73e-05 | 1443 | 22 | 8 | int:CEBPB | |
| Interaction | AIF1 interactions | 8.81e-05 | 13 | 22 | 2 | int:AIF1 | |
| Interaction | SEC24A interactions | 9.29e-05 | 224 | 22 | 4 | int:SEC24A | |
| Interaction | PDGFB interactions | 1.17e-04 | 88 | 22 | 3 | int:PDGFB | |
| Interaction | STH interactions | 1.72e-04 | 18 | 22 | 2 | int:STH | |
| Interaction | HABP2 interactions | 1.72e-04 | 18 | 22 | 2 | int:HABP2 | |
| Interaction | ST13P4 interactions | 1.92e-04 | 19 | 22 | 2 | int:ST13P4 | |
| Interaction | OSM interactions | 2.14e-04 | 20 | 22 | 2 | int:OSM | |
| Interaction | FN1 interactions | 2.28e-04 | 848 | 22 | 6 | int:FN1 | |
| Interaction | FUBP3 interactions | 2.74e-04 | 297 | 22 | 4 | int:FUBP3 | |
| Interaction | P4HA1 interactions | 2.78e-04 | 298 | 22 | 4 | int:P4HA1 | |
| Interaction | SCARA5 interactions | 2.84e-04 | 23 | 22 | 2 | int:SCARA5 | |
| Interaction | TGFBI interactions | 3.36e-04 | 25 | 22 | 2 | int:TGFBI | |
| Interaction | THBS1 interactions | 3.45e-04 | 127 | 22 | 3 | int:THBS1 | |
| Interaction | LGALS9 interactions | 3.62e-04 | 588 | 22 | 5 | int:LGALS9 | |
| Interaction | BIRC3 interactions | 3.87e-04 | 1334 | 22 | 7 | int:BIRC3 | |
| Interaction | HNRNPA1 interactions | 4.09e-04 | 945 | 22 | 6 | int:HNRNPA1 | |
| Interaction | DAZL interactions | 5.08e-04 | 145 | 22 | 3 | int:DAZL | |
| Interaction | SUZ12 interactions | 5.50e-04 | 644 | 22 | 5 | int:SUZ12 | |
| Interaction | SMC5 interactions | 5.53e-04 | 1000 | 22 | 6 | int:SMC5 | |
| Interaction | DYRK4 interactions | 5.88e-04 | 33 | 22 | 2 | int:DYRK4 | |
| Interaction | PUF60 interactions | 6.23e-04 | 369 | 22 | 4 | int:PUF60 | |
| Interaction | IPP interactions | 6.25e-04 | 34 | 22 | 2 | int:IPP | |
| Interaction | MEN1 interactions | 6.43e-04 | 1029 | 22 | 6 | int:MEN1 | |
| Interaction | USP48 interactions | 6.49e-04 | 668 | 22 | 5 | int:USP48 | |
| Interaction | YLPM1 interactions | 6.77e-04 | 160 | 22 | 3 | int:YLPM1 | |
| Interaction | ARFGAP2 interactions | 7.80e-04 | 168 | 22 | 3 | int:ARFGAP2 | |
| Interaction | TIAL1 interactions | 8.35e-04 | 172 | 22 | 3 | int:TIAL1 | |
| Interaction | CHMP4B interactions | 9.52e-04 | 727 | 22 | 5 | int:CHMP4B | |
| Interaction | MDC1 interactions | 9.57e-04 | 414 | 22 | 4 | int:MDC1 | |
| Interaction | PLOD3 interactions | 9.99e-04 | 183 | 22 | 3 | int:PLOD3 | |
| Interaction | NUP35 interactions | 1.05e-03 | 424 | 22 | 4 | int:NUP35 | |
| Interaction | ALG2 interactions | 1.05e-03 | 44 | 22 | 2 | int:ALG2 | |
| Interaction | RNPS1 interactions | 1.06e-03 | 425 | 22 | 4 | int:RNPS1 | |
| Interaction | SEC16A interactions | 1.06e-03 | 426 | 22 | 4 | int:SEC16A | |
| Interaction | CD93 interactions | 1.09e-03 | 45 | 22 | 2 | int:CD93 | |
| Interaction | FUS interactions | 1.14e-03 | 757 | 22 | 5 | int:FUS | |
| Interaction | CNTRL interactions | 1.16e-03 | 193 | 22 | 3 | int:CNTRL | |
| Interaction | PRNP interactions | 1.20e-03 | 1158 | 22 | 6 | int:PRNP | |
| Interaction | SMUG1 interactions | 1.24e-03 | 48 | 22 | 2 | int:SMUG1 | |
| Interaction | PKNOX2 interactions | 1.24e-03 | 48 | 22 | 2 | int:PKNOX2 | |
| Interaction | TRIM33 interactions | 1.34e-03 | 453 | 22 | 4 | int:TRIM33 | |
| Interaction | TRIM31 interactions | 1.35e-03 | 454 | 22 | 4 | int:TRIM31 | |
| Interaction | PDCD6 interactions | 1.37e-03 | 204 | 22 | 3 | int:PDCD6 | |
| Interaction | SEC24C interactions | 1.42e-03 | 207 | 22 | 3 | int:SEC24C | |
| Interaction | GCNT2 interactions | 1.46e-03 | 52 | 22 | 2 | int:GCNT2 | |
| Interaction | MKRN3 interactions | 1.48e-03 | 210 | 22 | 3 | int:MKRN3 | |
| Interaction | NR4A1 interactions | 1.52e-03 | 212 | 22 | 3 | int:NR4A1 | |
| Interaction | PRRC1 interactions | 1.63e-03 | 55 | 22 | 2 | int:PRRC1 | |
| Interaction | SNRPA interactions | 1.68e-03 | 482 | 22 | 4 | int:SNRPA | |
| Interaction | LDB2 interactions | 1.69e-03 | 56 | 22 | 2 | int:LDB2 | |
| Interaction | SERPINE2 interactions | 1.69e-03 | 56 | 22 | 2 | int:SERPINE2 | |
| Interaction | CEBPA interactions | 1.74e-03 | 1245 | 22 | 6 | int:CEBPA | |
| Interaction | VPS37B interactions | 1.75e-03 | 57 | 22 | 2 | int:VPS37B | |
| Interaction | HDLBP interactions | 1.96e-03 | 855 | 22 | 5 | int:HDLBP | |
| Interaction | NDRG1 interactions | 2.05e-03 | 235 | 22 | 3 | int:NDRG1 | |
| Interaction | USHBP1 interactions | 2.12e-03 | 238 | 22 | 3 | int:USHBP1 | |
| Interaction | CBL interactions | 2.15e-03 | 516 | 22 | 4 | int:CBL | |
| Interaction | COL2A1 interactions | 2.20e-03 | 64 | 22 | 2 | int:COL2A1 | |
| Interaction | EYA4 interactions | 2.25e-03 | 243 | 22 | 3 | int:EYA4 | |
| Interaction | SMAD1 interactions | 2.25e-03 | 243 | 22 | 3 | int:SMAD1 | |
| Interaction | SPARC interactions | 2.27e-03 | 65 | 22 | 2 | int:SPARC | |
| Interaction | COL5A1 interactions | 2.27e-03 | 65 | 22 | 2 | int:COL5A1 | |
| Interaction | RSU1 interactions | 2.27e-03 | 65 | 22 | 2 | int:RSU1 | |
| Interaction | CPSF6 interactions | 2.31e-03 | 526 | 22 | 4 | int:CPSF6 | |
| Interaction | FBLN2 interactions | 2.34e-03 | 66 | 22 | 2 | int:FBLN2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.14e-04 | 797 | 22 | 4 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 1.96e-03 | 137 | 22 | 2 | chr1p35 | |
| Cytoband | 19p13.3 | 5.73e-03 | 237 | 22 | 2 | 19p13.3 | |
| GeneFamily | Collagens | 2.21e-17 | 46 | 17 | 8 | 490 | |
| Coexpression | NABA_COLLAGENS | 1.01e-17 | 44 | 22 | 8 | M3005 | |
| Coexpression | NABA_COLLAGENS | 3.20e-15 | 43 | 22 | 7 | MM17060 | |
| Coexpression | NABA_CORE_MATRISOME | 3.73e-11 | 275 | 22 | 8 | M5884 | |
| Coexpression | NABA_CORE_MATRISOME | 1.70e-09 | 270 | 22 | 7 | MM17057 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 4.61e-07 | 369 | 22 | 6 | MM16610 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 5.83e-07 | 200 | 22 | 5 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.99e-07 | 23 | 22 | 3 | M48001 | |
| Coexpression | NABA_MATRISOME | 1.05e-06 | 1026 | 22 | 8 | M5889 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.85e-06 | 29 | 22 | 3 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.46e-06 | 268 | 22 | 5 | M45796 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 9.80e-06 | 50 | 22 | 3 | M7337 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.01e-05 | 6 | 22 | 2 | M48000 | |
| Coexpression | NABA_MATRISOME | 1.25e-05 | 1008 | 22 | 7 | MM17056 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.43e-05 | 385 | 22 | 5 | M39264 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.57e-05 | 681 | 22 | 6 | M39175 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.62e-05 | 59 | 22 | 3 | M47993 | |
| Coexpression | GSE17721_0.5H_VS_12H_LPS_BMDC_DN | 2.12e-05 | 199 | 22 | 4 | M4069 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.48e-05 | 68 | 22 | 3 | M1373 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.83e-05 | 71 | 22 | 3 | M3955 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.95e-05 | 72 | 22 | 3 | MM1131 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.95e-05 | 72 | 22 | 3 | M9908 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 3.08e-05 | 767 | 22 | 6 | M39209 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 3.20e-05 | 74 | 22 | 3 | M13547 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 3.33e-05 | 75 | 22 | 3 | MM1084 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.68e-05 | 11 | 22 | 2 | M47997 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.07e-05 | 479 | 22 | 5 | M2573 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 4.09e-05 | 807 | 22 | 6 | M16651 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 4.20e-05 | 81 | 22 | 3 | M39253 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.23e-05 | 483 | 22 | 5 | MM1082 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 4.26e-05 | 238 | 22 | 4 | M12004 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 5.02e-05 | 86 | 22 | 3 | M39247 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 6.34e-05 | 93 | 22 | 3 | M4752 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 7.01e-05 | 15 | 22 | 2 | M9138 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 7.01e-05 | 15 | 22 | 2 | MM402 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 7.19e-05 | 97 | 22 | 3 | M45794 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 7.64e-05 | 99 | 22 | 3 | M39152 | |
| Coexpression | KANG_AR_TARGETS_UP | 9.08e-05 | 17 | 22 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 9.08e-05 | 17 | 22 | 2 | MM1297 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | 9.65e-05 | 942 | 22 | 6 | M8144 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 1.02e-04 | 1399 | 22 | 7 | M535 | |
| Coexpression | SUNG_METASTASIS_STROMA_UP | 1.04e-04 | 110 | 22 | 3 | M9483 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 1.06e-04 | 1407 | 22 | 7 | M14427 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 1.13e-04 | 113 | 22 | 3 | M43610 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.14e-04 | 19 | 22 | 2 | M15125 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.25e-04 | 117 | 22 | 3 | M39300 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.35e-04 | 120 | 22 | 3 | M42505 | |
| Coexpression | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC | 1.54e-04 | 22 | 22 | 2 | MM779 | |
| Coexpression | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC | 1.54e-04 | 22 | 22 | 2 | M1867 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.56e-04 | 126 | 22 | 3 | M39132 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.64e-04 | 337 | 22 | 4 | MM16606 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.93e-04 | 352 | 22 | 4 | M17471 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.00e-04 | 137 | 22 | 3 | M40313 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 2.59e-04 | 380 | 22 | 4 | M45714 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 2.66e-04 | 151 | 22 | 3 | M8901 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 2.99e-04 | 157 | 22 | 3 | MM1099 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 3.11e-04 | 399 | 22 | 4 | M40939 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 3.33e-04 | 163 | 22 | 3 | M2769 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 3.50e-04 | 33 | 22 | 2 | M9167 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 3.82e-04 | 421 | 22 | 4 | MM985 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN | 3.93e-04 | 35 | 22 | 2 | M40938 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.93e-04 | 35 | 22 | 2 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.93e-04 | 35 | 22 | 2 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.16e-04 | 36 | 22 | 2 | MM1212 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 4.32e-04 | 794 | 22 | 5 | MM982 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.15e-04 | 40 | 22 | 2 | M5887 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 5.38e-04 | 192 | 22 | 3 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.54e-04 | 194 | 22 | 3 | M39122 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP | 5.80e-04 | 197 | 22 | 3 | M8414 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP | 5.88e-04 | 198 | 22 | 3 | M4982 | |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_DN | 5.97e-04 | 199 | 22 | 3 | M3702 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP | 5.97e-04 | 199 | 22 | 3 | M9077 | |
| Coexpression | GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP | 5.97e-04 | 199 | 22 | 3 | M5441 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_UP | 5.97e-04 | 199 | 22 | 3 | M5453 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_DN | 6.06e-04 | 200 | 22 | 3 | M6431 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M6263 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN | 6.06e-04 | 200 | 22 | 3 | M4527 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 6.06e-04 | 200 | 22 | 3 | M8833 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_DN | 6.06e-04 | 200 | 22 | 3 | M5748 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_DN | 6.06e-04 | 200 | 22 | 3 | M5750 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 6.06e-04 | 200 | 22 | 3 | M5261 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 6.23e-04 | 44 | 22 | 2 | M18274 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 6.91e-04 | 493 | 22 | 4 | M19391 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.11e-04 | 47 | 22 | 2 | M7585 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 7.41e-04 | 48 | 22 | 2 | M1246 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.56e-04 | 505 | 22 | 4 | M39167 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | 8.43e-04 | 520 | 22 | 4 | MM1008 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 9.66e-04 | 235 | 22 | 3 | M5311 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 9.66e-04 | 235 | 22 | 3 | M2256 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 1.16e-03 | 567 | 22 | 4 | M1097 | |
| Coexpression | DASU_IL6_SIGNALING_UP | 1.19e-03 | 61 | 22 | 2 | M14344 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.31e-03 | 261 | 22 | 3 | M1834 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.31e-03 | 64 | 22 | 2 | M2572 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 1.35e-03 | 65 | 22 | 2 | M41673 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.35e-03 | 65 | 22 | 2 | M39309 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 1.39e-03 | 267 | 22 | 3 | M6100 | |
| Coexpression | JI_RESPONSE_TO_FSH_UP | 1.48e-03 | 68 | 22 | 2 | M10355 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 1.50e-03 | 274 | 22 | 3 | M289 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.52e-03 | 69 | 22 | 2 | M10165 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | 1.55e-03 | 1054 | 22 | 5 | M45798 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 1.58e-03 | 616 | 22 | 4 | MM977 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_100 | 1.07e-04 | 15 | 22 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.16e-04 | 790 | 22 | 6 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.22e-04 | 797 | 22 | 6 | gudmap_developingGonad_P2_epididymis_1000 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-12 | 191 | 21 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-10 | 176 | 21 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-10 | 176 | 21 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.70e-10 | 190 | 21 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.78e-10 | 191 | 21 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-10 | 192 | 21 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-10 | 192 | 21 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.87e-10 | 192 | 21 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.96e-10 | 193 | 21 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-10 | 195 | 21 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-10 | 195 | 21 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-10 | 195 | 21 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-10 | 195 | 21 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-10 | 196 | 21 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-10 | 196 | 21 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-10 | 197 | 21 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-10 | 197 | 21 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-10 | 200 | 21 | 6 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-10 | 200 | 21 | 6 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-09 | 155 | 21 | 5 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-09 | 155 | 21 | 5 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-08 | 159 | 21 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-08 | 159 | 21 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.33e-08 | 168 | 21 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-08 | 177 | 21 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-08 | 177 | 21 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-08 | 178 | 21 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-08 | 184 | 21 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.21e-08 | 186 | 21 | 5 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.45e-08 | 190 | 21 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.45e-08 | 190 | 21 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.52e-08 | 191 | 21 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-08 | 192 | 21 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-08 | 192 | 21 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.59e-08 | 192 | 21 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-08 | 192 | 21 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.59e-08 | 192 | 21 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.72e-08 | 194 | 21 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 195 | 21 | 5 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 195 | 21 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.79e-08 | 195 | 21 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 195 | 21 | 5 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 195 | 21 | 5 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 195 | 21 | 5 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-08 | 196 | 21 | 5 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-08 | 196 | 21 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-08 | 196 | 21 | 5 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-08 | 196 | 21 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-08 | 196 | 21 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-08 | 196 | 21 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.87e-08 | 196 | 21 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-08 | 197 | 21 | 5 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-08 | 198 | 21 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-08 | 198 | 21 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-08 | 198 | 21 | 5 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-08 | 198 | 21 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-08 | 198 | 21 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-08 | 198 | 21 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-08 | 199 | 21 | 5 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.09e-08 | 199 | 21 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-08 | 199 | 21 | 5 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.09e-08 | 199 | 21 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.09e-08 | 199 | 21 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.09e-08 | 199 | 21 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 3.09e-08 | 199 | 21 | 5 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.09e-08 | 199 | 21 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-08 | 200 | 21 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.17e-08 | 200 | 21 | 5 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-08 | 200 | 21 | 5 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-08 | 200 | 21 | 5 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-08 | 200 | 21 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.17e-08 | 200 | 21 | 5 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-08 | 200 | 21 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.17e-08 | 200 | 21 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-08 | 200 | 21 | 5 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-08 | 200 | 21 | 5 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-08 | 200 | 21 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-08 | 200 | 21 | 5 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.17e-08 | 200 | 21 | 5 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.17e-08 | 200 | 21 | 5 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.15e-07 | 157 | 21 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-07 | 159 | 21 | 4 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-07 | 159 | 21 | 4 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-07 | 159 | 21 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-07 | 162 | 21 | 4 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-07 | 162 | 21 | 4 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-07 | 165 | 21 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 169 | 21 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.29e-06 | 176 | 21 | 4 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 178 | 21 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 180 | 21 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 180 | 21 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-06 | 180 | 21 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-06 | 181 | 21 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.44e-06 | 181 | 21 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 181 | 21 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 181 | 21 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 182 | 21 | 4 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 182 | 21 | 4 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 183 | 21 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| Computational | Adhesion molecules. | 5.91e-05 | 141 | 17 | 4 | MODULE_122 | |
| Computational | Neighborhood of CDH11 | 6.91e-04 | 25 | 17 | 2 | GNF2_CDH11 | |
| Drug | GK-101 | 5.37e-13 | 36 | 21 | 6 | CID000161853 | |
| Drug | Madecassol | 2.57e-12 | 46 | 21 | 6 | CID000108062 | |
| Drug | d-indobufen | 4.35e-12 | 50 | 21 | 6 | CID000044562 | |
| Drug | ridogrel | 5.57e-12 | 52 | 21 | 6 | CID005362391 | |
| Drug | NSC49633 | 6.27e-12 | 53 | 21 | 6 | CID000023340 | |
| Drug | AC1LAKND | 1.67e-11 | 62 | 21 | 6 | CID000470146 | |
| Drug | DMSe | 2.04e-11 | 132 | 21 | 7 | CID000020796 | |
| Drug | BAPN | 3.87e-11 | 71 | 21 | 6 | CID000001647 | |
| Drug | malotilate | 3.87e-11 | 71 | 21 | 6 | CID000004006 | |
| Drug | AC1NMZ1B | 5.44e-11 | 75 | 21 | 6 | CID005034185 | |
| Drug | strontium ranelate | 6.39e-11 | 77 | 21 | 6 | CID006918182 | |
| Drug | halofuginone lactate | 1.17e-10 | 85 | 21 | 6 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.78e-10 | 91 | 21 | 6 | CID000000825 | |
| Drug | ticlopidine | 3.80e-10 | 103 | 21 | 6 | CID000005472 | |
| Drug | hydroxylysine | 5.36e-10 | 109 | 21 | 6 | CID000001029 | |
| Drug | AC1L1C2F | 5.67e-10 | 110 | 21 | 6 | CID000001711 | |
| Drug | PPACK | 6.67e-10 | 113 | 21 | 6 | CID003036757 | |
| Drug | AC1L9732 | 7.04e-10 | 114 | 21 | 6 | CID000439300 | |
| Drug | Tranilast sodium | 7.42e-10 | 115 | 21 | 6 | CID000005527 | |
| Drug | Selara | 1.23e-09 | 125 | 21 | 6 | CID000150310 | |
| Drug | pirfenidone | 2.24e-09 | 138 | 21 | 6 | CID000040632 | |
| Drug | DL-penicillamine | 2.34e-09 | 139 | 21 | 6 | CID000004727 | |
| Drug | PCR 4099 | 2.34e-09 | 139 | 21 | 6 | CID000002806 | |
| Drug | candesartan cilexetil | 3.02e-09 | 145 | 21 | 6 | CID000002540 | |
| Drug | L-3,4-dehydroproline | 5.76e-09 | 73 | 21 | 5 | CID000094284 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 5.87e-09 | 162 | 21 | 6 | CID000072363 | |
| Drug | khellin | 8.12e-09 | 171 | 21 | 6 | CID000003828 | |
| Drug | AC1L1DD6 | 1.07e-08 | 179 | 21 | 6 | CID000002299 | |
| Drug | BPAT-143 | 1.35e-08 | 6 | 21 | 3 | CID000146249 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.48e-08 | 189 | 21 | 6 | CID000001413 | |
| Drug | foscarnet | 1.53e-08 | 190 | 21 | 6 | CID000003414 | |
| Drug | AC1Q6PCP | 4.76e-08 | 230 | 21 | 6 | CID000005267 | |
| Drug | prostacyclin sodium salt | 7.80e-08 | 250 | 21 | 6 | CID000000159 | |
| Drug | hyaluronan | 1.05e-07 | 263 | 21 | 6 | CID000024759 | |
| Drug | silibinin | 1.69e-07 | 285 | 21 | 6 | CID000005213 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 2.99e-07 | 314 | 21 | 6 | CID000447989 | |
| Drug | AC1L18QD | 3.66e-07 | 325 | 21 | 6 | CID000000213 | |
| Drug | 351A | 7.63e-07 | 20 | 21 | 3 | CID000122144 | |
| Drug | losartan | 8.85e-07 | 378 | 21 | 6 | CID000003961 | |
| Drug | colchine | 9.55e-07 | 383 | 21 | 6 | CID000002833 | |
| Drug | chondroitin sulfate | 1.48e-06 | 413 | 21 | 6 | CID000024766 | |
| Drug | D3273 | 1.55e-06 | 94 | 21 | 4 | CID005464587 | |
| Drug | Y-27632 | 2.25e-06 | 444 | 21 | 6 | CID000005711 | |
| Drug | AC1L1KMJ | 3.36e-06 | 476 | 21 | 6 | CID000030956 | |
| Drug | isodesmosine | 3.62e-06 | 33 | 21 | 3 | CID000013811 | |
| Drug | Sirius red | 4.34e-06 | 35 | 21 | 3 | CID005486818 | |
| Drug | AC1MRIIV | 6.05e-06 | 39 | 21 | 3 | CID003518584 | |
| Drug | PD123177 | 8.15e-06 | 43 | 21 | 3 | CID000114899 | |
| Drug | NC-4 | 8.74e-06 | 44 | 21 | 3 | CID006420119 | |
| Drug | aspirin | 8.80e-06 | 563 | 21 | 6 | CID000002244 | |
| Drug | Diphosphonates | 1.21e-05 | 6 | 21 | 2 | ctd:D004164 | |
| Drug | desmosine | 1.54e-05 | 53 | 21 | 3 | CID000025435 | |
| Drug | trapidil | 1.92e-05 | 57 | 21 | 3 | CID000005531 | |
| Drug | LMWH | 2.23e-05 | 663 | 21 | 6 | CID000000772 | |
| Drug | AC1Q641C | 2.47e-05 | 62 | 21 | 3 | CID000005005 | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 7513_DN | |
| Drug | U0125; Down 200; 1uM; PC3; HG-U133A | 2.90e-05 | 197 | 21 | 4 | 663_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 7517_DN | |
| Drug | 4-aminoazobenzene | 2.98e-05 | 66 | 21 | 3 | CID000006051 | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.08e-05 | 200 | 21 | 4 | 6766_UP | |
| Drug | homocystine | 5.71e-05 | 82 | 21 | 3 | CID000010010 | |
| Drug | LS-63783 | 6.55e-05 | 804 | 21 | 6 | CID000000231 | |
| Drug | AC1L9HPX | 8.06e-05 | 92 | 21 | 3 | CID000445279 | |
| Drug | pyridinoline | 1.00e-04 | 99 | 21 | 3 | CID000105068 | |
| Drug | carboxymethylcellulose | 1.69e-04 | 118 | 21 | 3 | CID000024748 | |
| Drug | 2,3-pentanedione | 2.19e-04 | 129 | 21 | 3 | ctd:C013186 | |
| Drug | calcium phosphate | 3.35e-04 | 149 | 21 | 3 | CID000024441 | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A | 5.36e-04 | 175 | 21 | 3 | 1746_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 5.36e-04 | 175 | 21 | 3 | 1006_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 5.54e-04 | 177 | 21 | 3 | 6943_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 6.01e-04 | 182 | 21 | 3 | 4989_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 6.11e-04 | 183 | 21 | 3 | 1206_UP | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.50e-04 | 187 | 21 | 3 | 5698_UP | |
| Drug | tripelennamine | 6.82e-04 | 42 | 21 | 2 | CID000005587 | |
| Drug | Domperidone maleate; Up 200; 7.4uM; PC3; HT_HG-U133A | 6.91e-04 | 191 | 21 | 3 | 4640_UP | |
| Drug | Asbestos, Serpentine | 6.96e-04 | 451 | 21 | 4 | ctd:D017632 | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 7.02e-04 | 192 | 21 | 3 | 3432_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 7.02e-04 | 192 | 21 | 3 | 5930_DN | |
| Drug | vicriviroc | 7.15e-04 | 43 | 21 | 2 | CID003009355 | |
| Drug | pyrachlostrobin | 7.16e-04 | 811 | 21 | 5 | ctd:C513428 | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 6883_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 4960_DN | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 7352_UP | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 7.34e-04 | 195 | 21 | 3 | 1138_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 4199_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 6255_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 4705_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 4101_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 7263_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 4540_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 3703_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 4078_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6284_UP | |
| Drug | STOCK1N-28457; Up 200; 20uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6864_UP | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 7164_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6137_UP | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 4240_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6012_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 3478_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.56e-04 | 197 | 21 | 3 | 959_UP | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.23e-06 | 53 | 22 | 3 | C4707243 | |
| Disease | Ehlers-Danlos syndrome | 1.48e-05 | 8 | 22 | 2 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.90e-05 | 9 | 22 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | collagen disease (implicated_via_orthology) | 3.49e-05 | 12 | 22 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Keloid | 3.11e-04 | 35 | 22 | 2 | C0022548 | |
| Disease | end stage renal disease (is_implicated_in) | 4.28e-04 | 41 | 22 | 2 | DOID:783 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 5.86e-04 | 48 | 22 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 7.42e-04 | 54 | 22 | 2 | C0149925 | |
| Disease | Cerebrovascular accident | 9.77e-04 | 62 | 22 | 2 | C0038454 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 1.11e-03 | 66 | 22 | 2 | EFO_0007708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGQPGYPGATGPPGL | 1086 | Q07092 | |
| PPGPQGPPGYGKMGA | 1536 | Q07092 | |
| PGQPGLPGYPGSPGA | 836 | P53420 | |
| PGGFPPPQGFPQGYG | 271 | Q96EP5 | |
| GFPGMQGPEGPQGPP | 61 | P02462 | |
| PGSPGPPGQPGYTNG | 416 | P02462 | |
| PGFPGQPGMPGRAGS | 546 | P02462 | |
| FMGPPGPQGQPGLPG | 1211 | P02462 | |
| FPGGFPGGMPGNFPG | 281 | Q8NFI4 | |
| FPGGFPGGMPGNFPG | 281 | P50502 | |
| GGMFSGQPPGPPQAP | 6 | Q9H204 | |
| GGPYGHPNPGMFPSG | 61 | Q9UBV8 | |
| PPMPPPGYFGQANGP | 1001 | Q92900 | |
| QGFGYPGEQGPPGPP | 881 | Q96P44 | |
| GQGPPGPQGPIGYPG | 776 | P20908 | |
| PGFMGPPGNPGPPGA | 1191 | Q8NFW1 | |
| PGSPGSPGYQGPPGE | 191 | P02461 | |
| AQGPPGSAGPPGYPG | 696 | P25940 | |
| PGGPGPAGPMGPFNP | 506 | Q92945 | |
| SPGNYVGPPGGGGPP | 236 | P81877 | |
| PQGPSMGPPGYGGNP | 71 | Q96GM5 | |
| MGPPGYGGNPSVRPG | 76 | Q96GM5 | |
| GFPGGPAQMAGPPQP | 241 | O94855 | |
| GMPGGISPYPSGYPP | 166 | Q99816 | |
| VMPGGGYGDWQPPPP | 91 | P49750 | |
| PGYLPGAMPPYGQGP | 436 | O43670 | |
| YGQGPPMVPPYQGGP | 446 | O43670 | |
| PQGPPGTQGMQGPPG | 731 | Q9C0J8 | |
| PPPQGGMQGPPGPQG | 871 | Q9C0J8 |